| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.73B | — |
| Cost of Revenue | $2.43B | -3.8% |
| Gross Profit | $302.9M | +4.2% |
| R&D Expense | $82.8M | -1.5% |
| SG&A Expense | $207.6M | -3.8% |
| Operating Income | $69.8M | +51.7% |
| Pre-tax Income | -$101.5M | +47.8% |
| Income Tax | -$23.3M | -361.4% |
| Net Income | -$78.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $170.0M | +9.8% |
| Accounts Receivable | $310.7M | -18.3% |
| Inventory | $142.4M | -3.0% |
| Current Assets | $805.3M | -10.6% |
| Total Assets | $1.73B | -7.4% |
| Current Liabilities | $576.8M | -11.7% |
| Long-term Debt | $1.06B | +1.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $76.4M | -34.9% |
| Investing Cash Flow | -$45.1M | +30.6% |
| Financing Cash Flow | -$9.6M | +88.1% |
| +61.0% |
| EPS (Basic) | -$4.48 | +61.5% |
| EPS (Diluted) | -$4.48 | +61.5% |
| Total Liabilities |
| $1.87B |
| -4.9% |
| Stockholders' Equity | -$125.8M | -54.7% |